Epidemiological aspects of irritable bowel syndrome in Europe and North America.

S. Muller-Lissner*, S. Bollani, R.J.M. Brummer, G. Coremans, M. Dapoigny, J.R. Marshall, J.W.M. Muris, A.H. Oberndorff-Klein Woolthuis, F. Pace, L. Rodrigo, R.W. Stockbrügger, M.H. Vatn

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review


The epidemiology of irritable bowel syndrome (IBS) in Europe and North America was analyzed from published material. The percentage of the population of Western civilisation with IBS symptoms is between 10 and 15% in most studies. The proportion of a Western population visiting a doctor for IBS symptoms is around 5%. The prevalence of IBS and the proportion of consulters do not seem to depend on age in an adult population. The female-to-male ratio of IBS in the population is close to 2. It is higher in IBS consulters in primary care and may be as high as 3 or 4 in tertiary referral centers. At least in patients from these centers, the number of physician visits and colonoscopies is considerable. Most of the consulters get a drug prescription. Copyright 2001 S. Karger AG, Basel
Original languageEnglish
Pages (from-to)200-204
Number of pages5
Issue number3
Publication statusPublished - 1 Jan 2001


Dive into the research topics of 'Epidemiological aspects of irritable bowel syndrome in Europe and North America.'. Together they form a unique fingerprint.

Cite this